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Abstract
We present the progressive nature of the disease in a 26 year-old woman who had suffered from
Emery-Dreifuss muscular dystrophy detected at the age of three. In 2002, at the age of 20, due
to recurring presyncopal states accompanied by sinus bradycardia and atrioventricular block,
she was implanted with a dual chamber pacing system. During testing of the pacing in 2008,
permanent electrical atrial stand-still without atria stimulation were detected and the mode of
heart stimulation was changed to VVIR. (Cardiol J 2011; 18, 2: 189–193)
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Introduction
Emery-Dreifuss muscular dystrophy (EDMD)
is a rare disease classically inherited in an X-linked
recessive fashion. It is characterized by: early con-
tractures  of the elbow and posterior cervical mus-
cles with joint stiffening and dislocation, progres-
sive muscle weakness beginning in childhood, atro-
phy primarily in humeroperoneal muscles, and
cardiac involvement. Muscular dystrophy manifests
itself in the patient in relatively benign changes in
the muscular system, such as contracture of the
elbow and ankle joints with weakening of the limb
muscles which, to some extent, affect motor ability.
Although female carriers of the disease do not
show the full spectrum of symptoms, they may de-
velop cardiac conduction system defects [1].
Arrhythmias and dilated cardiomyopathy are
the major manifestations of cardiac disease in the
course of EDMD. Abnormalities in impulse gene-
ration and conduction are relatively frequent. Typi-
cal disorders of the electrophysiological properties
include: the first type of atrioventricular block pro-
gressing to the second and third type of block, su-
praventricular rhythm disorders, atrial electrical
silence as well as ventricular rhythm disorders
which may be malignant and lead to sudden death.
Frequently, permanent pacing is required for symp-
tomatic bradycardia or heart block [2].
Case report
The case presented is of a 26 year-old woman
who had EDMD detected at the age of three. The
patient’s father suffered from dilated cardiomyopa-
thy and, following implantation of a heart pacema-
ker, died suddenly at the age of 32.
The patient has been under cardiac observa-
tion since the age of 12. Early electrographic (ECG)
Holter monitoring performed between 1994 and
2000 did not show significant sinus bradycardia.
However, over the years, there was some progres-
sion in supraventricular disorders of heart rhythm.
Episodes of atrial fibrillation and flutter became
more frequent and lasted longer. At first, only sin-
gle premature ventricular beats were observed. In
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2000, during a 24-hour ECG recording, pairs of ven-
tricular beats were recorded, together with one ep-
isode of ventricular tachycardia comprising 12 beats.
In 2002, at the age of 20, the patient suffered
from recurring presyncopal states. Standard and
24-hour ECG readings showed sinus bradycardia
45–56 bpm, with first-degree atrioventricular block,
and supraventricular rhythm disorders, especially
episodes of atrial fibrillation and flutter. What was
striking was the small amplitude and short duration
of P-waves (Fig. 1). Echocardiography recordings
showed normal heart structures with proper left
ventricular systolic and diastolic function. Due to
symptomatic sinus bradycardia, disorders in atrio-
ventricular conduction with first degree block type,
the patient with EDMD had a two-chamber stimu-
lation system implanted, functioning in DDDR
mode [3]. Additionally, 100 mg/day of metoprolole
was administered.
In the years 2002–2008, the patient’s condition
was satisfactory. There were no occurrences of
syncope or symptomatic tachyarrhythmia. The
heart stimulation system, functioning in DDD
mode, was used to its full capacity.
During one of the most recent examinations of
the stimulation system, there was no atria stimula-
tion detected, despite the maximum energy of the
stimulating impulse. The stimulation of ventricles
was correct and there was no significant change in
the level of stimulation. After switching off the sti-
mulation system, an atrioventricular junctional
rhythm of 35–40 bpm was observed (Fig. 2). At the
same time, zero potential from the right auricle of
the heart was recorded, which could attest to a per-
manent electrical atrial stand-still. Other parame-
ters of the stimulator did not change significantly
and remained at acceptable values. Radiological
examination did not show any change in the loca-
tion of the atrial electrode. The echocardiography
examination, compared to earlier recordings, re-
vealed dilatation of both atria (Fig. 3) without he-
modynamic function (lack of ‘A’ wave in the Dop-
pler mitral flow pattern).
Due to the lack of effective atrial stimulation,
the mode of heart stimulation was changed to VVIR.
The patient remains under constant cardiac care
with periodic echocardiography examination of the
heart and the progression of rhythm disorders (24-
-hour ECG monitoring), which may influence further
decisions as to the possible implantation of a car-
dioverter-defibrillator (ICD) in order to prevent
sudden cardiac death.
Discussion
Emery-Dreifuss is a primary muscular, gene-
tically conditioned disease. It is most frequently in-
herited in an X-linked recessive fashion, although
occasionally it may take the autosomal dominant
form. The gene responsible for X-linked EDMD is
emerine, located in chromosome Xq28 [4]. Muscu-
lar defect is primary in comparison to the changes
Figure 1. Sinus bradycardia 51 bpm, small amplitude and short duration (0.04 s) of P-waves, first-degree atrioventri-
cular block.
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taking place in the nerve endings of dystrophic
muscles, which are secondary. EDMD has its on-
set between the ages of three and six. Among the
earliest features of this disorder are contractures
in elbow and ankle joints, as well as slowly progres-
sive perineal, brachial and scapular muscle weak-
ness. There is no muscle hypertrophy and no weak-
ness of facial muscles. Deep movements are usual-
ly suppressed. Mental development is good [5].
The activity of phosphorylase kinase in blood
serum is usually slightly increased. Muscle fibre
necrosis is diagnosed by muscle biopsy and the pro-
liferation of the connective tissue in endomyosium.
Immunofluorescence tests detect the presence of
Figure 3. Echocardiography examination: apical four chamber view, atrial enlargement.
Figure 2. Atrioventricular junctional rhythm 44 bpm, P-waves are missing.
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emerine at the nuclear membrane of muscle cells
and skin specimens [4, 5].
The clinical course varies and depends mostly
on two factors: weakening of muscle strength and
organ complications, such as disorders of the heart
rhythm and conductivity [4, 5]. In this type of dys-
trophy, heart disorders are manifested in various
conductivity disorders: from the prolongation of P-Q
interval to atrial paralysis, atrial mechanical and elec-
trical silence, left anterior bundle branch block, QRS
prolongation, complete heart block with sudden car-
diac death, which can be prevented by the implanta-
tion of a pacemaker or prophylactic ICD placement
[6–8].
In classic cases, atrioventricular first degree
block progressing to third degree block takes place
in the second or third decade of life [2]. ECG chang-
es detect the disease in the heart muscle, the con-
duction system of the heart on various levels, and
the vessels that supply it. Both autopsy and myo-
cardial biopsies detect fibrosis, fatty degeneration
and atrophy of nodal tissue, atrioventricular node
tissue, His bundle and its branches [9].
Common rhythm disorders include: additional
junctional beat, sinus bradycardia, paroxysmal su-
praventricular tachycardia, atrial fibrillation and flut-
tering and ventricular tachycardia [10]. Ventricu-
lar rhythm disorders may be a cause of sudden
death. There are also cases with detected prolonged
QT interval and torsade de pointes ventricular ta-
chycardia [11]. The causes of ventricular arrhyth-
mia vary and may be connected to the presence of
late ventricular potentials and slow conductivity of
ventricular muscles [12]. An additional pro-arrhyth-
mic factor is low coronary reserve present in asym-
ptomatic patients with normal left ventricle func-
tion. Additionally, dystrophic and myotonic chang-
es in tissue cells of the heart muscle may lead to
disorders of systolic and diastolic function and in-
directly cause arrhythmia [13]. In patients suffer-
ing from muscular dystrophy, there might also be
tachycardia coming from His bundle branches. This
mechanism is present in symptomatic patients with
tachycardia with broad QRS complexes [14]. Heart
complications which cause sudden death may oc-
cur even in asymptomatic patients suffering from
muscular dystrophy.
In 1999, based on previous results, Lazarus et
al. [2] proposed an algorithm for the treatment of
patients suffering from muscular dystrophy. The
algorithm comprises electrophysiological examina-
tion when there are symptoms which might be con-
nected with rhythm or conductivity disorders, even
with normal ECG results. The implantation of
a pacemaker was recommended in patients with
conventional indications as well as in asymptomat-
ic patients, although with the prolongation of con-
ductivity in His bundle to 70 ms. According to Eu-
ropean Society of Cardiology guidelines of 2007
[15], the implantation of a pacemaker is recom-
mended for patients with muscular dystrophy in the
presence of third degree atrioventricular block and
second degree Mobitz I and II types (class I of the
guidelines). The implantation may be considered
for patients with first degree atrioventricular block
(class IIb of the guidelines). The implantation of a pace-
maker is also recommended in the case of any block
of His bundle branch (class IIa of the guidelines).
In comparison with Duchenne muscular dys-
trophy, EDMD progresses slowly and benignly.
However, heart disorders constitute a serious prob-
lem. In our patient, the occupation of skeletal mus-
cles was typical: contractions of elbow and ankle
muscles with muscle weakening. Until the age of
20, there was no damage to the heart muscle de-
tected by echocardiography examination. Initially,
heart complications were connected with the dys-
function of sinus node with progressing bradycardia
and supraventricular rhythm disorders. Due to symp-
tomatic tachy-bradycardia with first degree atrioven-
tricular block, a two-chamber stimulation system was
implanted. At first, electrical and mechanical activi-
ty was good. However, attention was paid to P-wave
morphology of low voltage and short duration which
would testify in this case to electrical and mechani-
cal atrial paralysis, which manifested itself six years
later.
The patient’s father, most probably suffering
from EDMD, had the symptoms of dilated cardiomyo-
pathy and died suddenly in spite of the implanta-
tion of a heart pacemaker. Dilated cardiomyopathy
is more common in patients whose chances of sur-
vival have been improved by pacemaker implanta-
tion. EDMD is a disease inherited as a recessive
chromosome X-linked feature, which makes the di-
sease fully symptomatic in male patients, whereas
in female patients not all symptoms are manifested.
The placement of a heart pacemaker is the
treatment of choice in progressive damage of the
stimulus conduction system in patients with EDMD
[2, 6]. It does not protect from the consequences of
malignant ventricular arrhythmia. So far, there are
no guidelines for the implantation of ICD for pri-
mary prevention in patients suffering from muscu-
lar dystrophy without echocardiographical features
testifying to the damage of left ventricular systolic
action. The prognostic value of electrophysiological
examination for this group of patients remains un-
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known. However, the family history, as well as ob-
served episodes of ventricular tachycardia detect-
ed by 24 hour ECG monitoring, and the progres-
sive nature of the disease, constitute factors of
potentially unfavourable prognosis. Continuing
thorough observation of the patient is required, with
the issue of qualifying the patient according to ICD
remaining open.
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